An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab

Trial Identifier: D9180C00006
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: April 2025
Primary Completion Date: November 2025
Study Completion Date: November 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DE Berlin, DE, 14050
GB Harrow, GB, HA1 3UJ
US, CA Glendale, CA, US, 91206
US, MD Baltimore, MD, US, 21225